Search

Your search keyword '"O. Koita"' showing total 75 results

Search Constraints

Start Over You searched for: Author "O. Koita" Remove constraint Author: "O. Koita"
75 results on '"O. Koita"'

Search Results

3. Therapeutic efficacy of artemether–lumefantrine and artesunate–amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali, 2015–2016

4. Characterization of New Races of Xanthomonas oryzae pv. oryzae in Mali Informs Resistance Gene Deployment

6. Evaluation du paludisme dans une cohorte randomisée d'enfants (6 mois- 6 ans) au niveau de deux sites de transmission différente au cours de la saison 2001: Sotuba et Donéguébougou au Mali.

7. Spatio-Temporal Dynamic of Malaria Incidence: A Comparison of Two Ecological Zones in Mali

8. AQ-13, an investigational antimalarial, versus artemether plus lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria: a randomised, phase 2, non-inferiority clinical trial

10. Characterization of New Races of

11. Expanding Research Capacity in Sub-Saharan Africa Through Informatics, Bioinformatics, and Data Science Training Programs in Mali

12. New Multilocus Variable-Number Tandem-Repeat Analysis Tool for Surveillance and Local Epidemiology of Bacterial Leaf Blight and Bacterial Leaf Streak of Rice Caused by Xanthomonas oryzae

13. High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali

14. Laboratory Response to 2014 Ebola Virus Outbreak in Mali

15. Assessing Community Readiness to Reduce Childhood Diarrheal Disease and Improve Food Security in Dioro, Mali

16. Tuberculosis specific responses following therapy for TB: Impact of HIV co-infection

17. Antiretroviral induced adverse drug reactions in HIV infected patients in Mali: A resource-limited setting

18. Analysis of Xanthomonas oryzae pv. oryzicola population in Mali and Burkina Faso reveals a high level of genetic and pathogenic diversity

19. A prospective study of the association between the human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malarial infections

20. First Report of Cassava Bacterial Blight Caused by Xanthomonas axonopodis pv. manihotis in Burkina Faso

21. First report of Pepo aphid‐borne yellows virus on zucchini in Cote d'Ivoire

22. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali]

23. Analysis of the human antibody response to thrombospondin-related anonymous protein of Plasmodium falciparum

24. [Incidence of malaria and S hemoglobinopathy in the pediatric hospital milieu in Bamako, Mali]

25. [Impact of curtains and blankets impregnated with permethrin on the malarial indicators and the number of malarial attacks per child in a village in an area hyperendemic for malaria on the Malian savannah (preliminary results of the first year study)]

26. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short-lived

27. Pediatric HIV infection due to maternal transmission: a solvable problem in a peri-urban setting in Bamako, Mali

28. A decade of partnering to stop HIV in West Africa: GAIA VF prevention, education, access to care and vaccine trial site development in Bamako, Mali

29. Evolutionary and epidemiological insights from historical and modern genomes of Xanthomonas oryzae pv. oryzicola , the causal agent of bacterial leaf streak of rice.

30. First report of V1016I, F1534C and V410L kdr mutations associated with pyrethroid resistance in Aedes aegypti populations from Niamey, Niger.

31. Protocol for a parallel group, two-arm, superiority cluster randomised trial to evaluate a community-level complementary-food safety and hygiene and nutrition intervention in Mali: the MaaCiwara study (version 1.3; 10 November 2022).

32. Retraction.

33. RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa.

34. Orthopoxvirus Seroprevalence and Infection Susceptibility in France, Bolivia, Laos, and Mali.

35. Insufficient yet improving involvement of the global south in top sustainability science publications.

36. A Randomized Controlled Trial of Dietary Rice Bran Intake on Microbiota Diversity, Enteric Dysfunction, and Fecal Secretory IgA in Malian and Nicaraguan Infants.

37. The Rice ILI2 Locus Is a Bidirectional Target of the African Xanthomonas oryzae pv. oryzae Major Transcription Activator-like Effector TalC but Does Not Contribute to Disease Susceptibility.

38. Agonist-Specific Regulation of G Protein-Coupled Receptors after Chronic Opioid Treatment.

39. Arsenic speciation in rice bran: Agronomic practices, postharvest fermentation, and human health risk assessment across the lifespan.

40. Structure of African Populations of Pyricularia oryzae from Rice.

41. Plasmodium falciparum kelch 13 Mutations, 9 Countries in Africa, 2014-2018.

42. A ventrolateral medulla-midline thalamic circuit for hypoglycemic feeding.

44. Anopheles gambiae (s.l.) exhibit high intensity pyrethroid resistance throughout Southern and Central Mali (2016-2018): PBO or next generation LLINs may provide greater control.

45. Characterization of New Races of Xanthomonas oryzae pv. oryzae in Mali Informs Resistance Gene Deployment.

46. Separation of Acute Desensitization and Long-Term Tolerance of µ -Opioid Receptors Is Determined by the Degree of C-Terminal Phosphorylation.

47. Rice bran supplementation modulates growth, microbiota and metabolome in weaning infants: a clinical trial in Nicaragua and Mali.

48. A Pathovar of Xanthomonas oryzae Infecting Wild Grasses Provides Insight Into the Evolution of Pathogenicity in Rice Agroecosystems.

49. Expanding Research Capacity in Sub-Saharan Africa Through Informatics, Bioinformatics, and Data Science Training Programs in Mali.

50. Comparative Rice Bran Metabolomics across Diverse Cultivars and Functional Rice Gene⁻Bran Metabolite Relationships.

Catalog

Books, media, physical & digital resources